220 related articles for article (PubMed ID: 37844630)
1. CTRP13 ablation improves systemic glucose and lipid metabolism.
Chen F; Sarver DC; Saqib M; Zhou M; Aja S; Seldin MM; Wong GW
Mol Metab; 2023 Dec; 78():101824. PubMed ID: 37844630
[TBL] [Abstract][Full Text] [Related]
2. Loss of CTRP1 disrupts glucose and lipid homeostasis.
Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
[TBL] [Abstract][Full Text] [Related]
3. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.
Tan SY; Lei X; Little HC; Rodriguez S; Sarver DC; Cao X; Wong GW
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E146-E162. PubMed ID: 32421370
[TBL] [Abstract][Full Text] [Related]
4. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
5. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
[TBL] [Abstract][Full Text] [Related]
6. Metabolic regulation by C1q/TNF-related protein-13 (CTRP13): activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling.
Wei Z; Peterson JM; Wong GW
J Biol Chem; 2011 May; 286(18):15652-65. PubMed ID: 21378161
[TBL] [Abstract][Full Text] [Related]
7. A central role for C1q/TNF-related protein 13 (CTRP13) in modulating food intake and body weight.
Byerly MS; Swanson R; Wei Z; Seldin MM; McCulloh PS; Wong GW
PLoS One; 2013; 8(4):e62862. PubMed ID: 23638159
[TBL] [Abstract][Full Text] [Related]
8. Glucose and lipid metabolism alterations in liver and adipose tissue pre-dispose p47
Kanuri BN; Rebello SC; Pathak P; Agarwal H; Kanshana JS; Awasthi D; Gupta AP; Gayen JR; Jagavelu K; Dikshit M
Free Radic Res; 2018 May; 52(5):568-582. PubMed ID: 29544378
[TBL] [Abstract][Full Text] [Related]
9. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
[TBL] [Abstract][Full Text] [Related]
10. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
12. Spinophilin-deficient mice are protected from diet-induced obesity and insulin resistance.
Zhang Y; Song L; Dong H; Kim DS; Sun Z; Boger H; Wang Q; Wang H
Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E354-E362. PubMed ID: 32603260
[TBL] [Abstract][Full Text] [Related]
13. Genetic Deletion of DNAJB3 Using CRISPR-Cas9, Produced Discordant Phenotypes.
Nejat S; Menikdiwela KR; Efotte A; Scoggin S; Vandanmagsar B; Thornalley PJ; Dehbi M; Moustaid-Moussa N
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895206
[TBL] [Abstract][Full Text] [Related]
14. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.
Guo T; Jou W; Chanturiya T; Portas J; Gavrilova O; McPherron AC
PLoS One; 2009; 4(3):e4937. PubMed ID: 19295913
[TBL] [Abstract][Full Text] [Related]
15. Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects.
Miller CO; Yang X; Lu K; Cao J; Herath K; Rosahl TW; Askew R; Pavlovic G; Zhou G; Li C; Akiyama TE
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E386-E393. PubMed ID: 29870677
[TBL] [Abstract][Full Text] [Related]
16. P2Y
Zhang Y; Ecelbarger CM; Lesniewski LA; Müller CE; Kishore BK
Front Endocrinol (Lausanne); 2020; 11():341. PubMed ID: 32582029
[TBL] [Abstract][Full Text] [Related]
17. Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease.
An K; Starkweather A; Sturgill J; Salyer J; Sterling RK
Nurs Res; 2019; 68(1):29-38. PubMed ID: 30247335
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder.
Zhang G; Li R; Li W; Yang S; Sun Q; Yin H; Wang C; Hou B; Wang H; Yu L; Chen R; Shi L; Zhang K; Liew CW; Qiang G; Sun Q; Liu C
J Nutr Biochem; 2021 Sep; 95():108761. PubMed ID: 33965533
[TBL] [Abstract][Full Text] [Related]
19. Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice.
Pfuhlmann K; Pfluger PT; Schriever SC; Müller TD; Tschöp MH; Stemmer K
PLoS One; 2017; 12(9):e0183488. PubMed ID: 28873424
[TBL] [Abstract][Full Text] [Related]
20. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.
Costa DK; Huckestein BR; Edmunds LR; Petersen MC; Nasiri A; Butrico GM; Abulizi A; Harmon DB; Lu C; Mantell BS; Hartman DJ; Camporez JP; O'Doherty RM; Cline GW; Shulman GI; Jurczak MJ
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E105-16. PubMed ID: 27166280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
